Xiaohui Gao
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
SPP1 as a central mediator in the tumor microenvironment: Orchestrating cellular crosstalk, immune evasion, and therapy resistance.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: August 21, 2025
Efficacy and safety of bevacizumab biosimilar SIBP04 compared with bevacizumab (Avastin®) as first-line treatment for locally advanced or metastatic non-squamous non-small-cell lung cancer: A randomized, double-blind, phase 3 trial.
Journal: Cancer pathogenesis and therapy
Published: November 08, 2024
First-line benmelstobart plus anlotinib and chemotherapy in advanced or metastatic/recurrent esophageal squamous cell carcinoma: a multi-center phase 2 study.
Journal: Signal transduction and targeted therapy
Published: June 03, 2024
SPP1 represents a therapeutic target that promotes the progression of oesophageal squamous cell carcinoma by driving M2 macrophage infiltration.
Journal: British journal of cancer
Published: December 03, 2023
Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression.
Journal: Cell communication and signaling : CCS
Published: October 15, 2023
Research progress of N1-methyladenosine RNA modification in cancer.
Journal: Cell communication and signaling : CCS
Published: October 14, 2023
Identification and Characterization of Prognostic Macrophage Subpopulations for Human Esophageal Carcinoma.
Journal: Current medicinal chemistry
Published: October 09, 2023
BBOX1-AS1: A novel oncogenic long non-coding RNA in human cancers.
Journal: Pathology, research and practice
Published: June 15, 2023
Tailoring second-line or above therapy for patients with advanced or metastatic gastric cancer: A multicenter real-world study.
Journal: Frontiers in pharmacology
Published: September 13, 2022
Clinical Study of Anlotinib as Third-Line or Above Therapy in Patients With Advanced or Metastatic Gastric Cancer: A Multicenter Retrospective Study.
Journal: Frontiers in oncology
Published: February 28, 2022
Last Updated: 09/26/2026